Incyte (INCY)

$61.83 0.25 (0.40%)

20:00 EDT INCY Stock Quote Delayed 30 Minutes

The 3 Most Undervalued Cathie Wood Stocks to Buy in July 2024

By Rich Duprey, InvestorPlace Contributor Jul 9, 2024

The stock market watches this investing guru's picks closely but these may be the best undervalued Cathie Wood stocks in her ETFs.

7 Cheap Biotech Stocks With Major Upside Potential

3 Highly Rated Biotech Stocks for Your July Buy List

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

Volume:

Previous Close $62.78

Market Cap 12.01B

PE Ratio 399.42

EPS 0.1548

Volume (Avg. Vol.) 2.41M

Day's Range $61.03 - $63.27

52-Week Range $50.35 - $83.95

Dividend & Yield N/A (N/A)

INCY Stock Predictions, Articles, and Incyte News

The 3 Best Biotech Stocks to Buy in May 2024

By Chandler Capital, InvestorPlace Contributor May 9, 2024

If you have the appetite for the risk inherent in the biotech sector, here are three biotech stocks to buy in May.

INCY Stock Earnings: Incyte Misses EPS, Misses Revenue for Q1 2024

By InvestorPlace Earnings Apr 30, 2024

INCY stock results show that Incyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Penny Stock Detox: 3 Stocks to Buy for Multibagger Returns Instead

By Rich Duprey, InvestorPlace Contributor Mar 11, 2024

Don't fall for the siren song of penny stocks. Rather, fill your portfolio with companies that have a proven track record of success.

3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise

By Shane Neagle, InvestorPlace Contributor Mar 7, 2024

Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

By Josh Enomoto, InvestorPlace Contributor Feb 26, 2024

While biotech stocks offer some of the most pertinent ideas available in the market, they can be awfully risky. One bad clinical result and boom…

Exit Now! 3 Biotech Stocks to Sell in February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 21, 2024

These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.

3 Pharma Stocks Could Be the Pills Your Portfolio Needs

By Chris Markoch, InvestorPlace Contributor Jan 18, 2024

These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.

The 3 Most Undervalued Biotech Stocks to Buy in December

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Dec 15, 2023

Biotech is an increasing area of interest in the financial markets, line your portfolio up with these winning biotech stocks.

3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024

By Larry Ramer, InvestorPlace Contributor Nov 12, 2023

Investors should consider these "Goldilocks" biotech stocks to buy as they are poised to get significant boosts next year.

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

By Josh Enomoto, InvestorPlace Contributor Nov 9, 2023

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall

By Chris Markoch, InvestorPlace Contributor Sep 20, 2023

Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy.

7 Biotech Stocks That Could Cure Your Portfolio Woes

By Josh Enomoto, InvestorPlace Contributor Apr 19, 2023

If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill.

7 Healthcare Stocks to Buy for Long-Term Growth and Stability

By Muslim Farooque, InvestorPlace Contributor Mar 21, 2023

These healthcare stocks to buy offer spectacular upside potential ahead in your defensive portfolio

7 Biotech Stocks That Will Make You Rich in 10 Years

By Josh Enomoto, InvestorPlace Contributor Jan 18, 2023

Although the health innovation space presents risks, the opportunities beckon a look at the biotech stocks that will make you rich in 10 years.

Why These 7 Healthcare Stocks Could Soar in 2023

By Muslim Farooque, InvestorPlace Contributor Jan 2, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

7 Undervalued Biotech Stocks to Buy Before They Boom

By Josh Enomoto, InvestorPlace Contributor Dec 29, 2022

While medical innovations offer tremendous appeal, investors can still get a discount in this sector via undervalued biotech stocks to buy.

The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond

By Thomas Niel, InvestorPlace Contributor Dec 18, 2022

As their respective catalysts (namely new treatments/products) continue to play out, each one of these seven hottest healthcare stocks has a strong chance of making another significant move higher in 2023, and in the years ahead.

7 Cash-Rich Stocks to Buy for Peace of Mind

By Will Ashworth, InvestorPlace Contributor Nov 4, 2022

It pays to hold cash-rich stocks that can weather any storm because of their financial strength. These seven stocks are such companies.

3 Nasdaq Stocks to Buy Now for Growth

By Tezcan Gecgil, InvestorPlace Contributor May 1, 2022

These are the best Nasdaq stocks to invest in now. INCY, ROKU and FTXL can make great investments in the rest of the year.

7 Insider Stocks to Buy as Execs Snap Them Up

By Josh Enomoto, InvestorPlace Contributor Feb 18, 2022

With equity prices soaring to record levels, many execs have cashed out. Here are the insider stocks where execs are cashing in.

Incyte (INCY)

The 3 Most Undervalued Cathie Wood Stocks to Buy in July 2024

7 Cheap Biotech Stocks With Major Upside Potential

3 Highly Rated Biotech Stocks for Your July Buy List

7 Undervalued Biotech Stocks to Buy for Big-Time Returns

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Incyte (INCY)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

INCY Stock Predictions, Articles, and Incyte News

Subscriber Sign in